back

April 25, 2014

Announcement on change of President

Kissei Pharmaceutical Co., Ltd.



At the meeting of our Company's Board of Directors on April 25, 2014, a decision was made to change the President as follows.

This change will be authorized at the regular shareholders' meeting and at the meeting of Board of Directors, both scheduled for June 27, 2014.


1.The reason for change

This change is intended to establish a new management structure that can be further consolidated and strengthened through improved dynamic capabilities. , The CEO (Chief Executive Officer) has overall responsibility for corporate management, while the COO (Chief Operating Officer) assumes overall responsibility for business.


2.The new roles

New title Name Current title
Chairman and Chief Executive Officer (CEO) Mutsuo Kanzawa President and Chief Executive Officer (CEO)
President and Chief Operating Officer (COO) Masaki Morozumi Managing Director, Division Director of Sales and Marketing Division


3.Resume of the new President

Name Resume Shares held
Masaki Morozumi
(born August 2, 1955)
April  1980 Joined Kissei Pharmaceutical Co., Ltd.
October 2004 Regional Director, Kanetsu Branch,
          Sales and Marketing Division
October 2006 Regional Director, Osaka Branch,
          Sales and Marketing Division
June  2008 Member of the Board, Associate Division
          Director of Sales and Marketing Division
June  2010 Member of the Board, Division Director of
          Sales and Marketing Division
June  2012 Managing Director, Division Director of Sales
          and Marketing Division (to the present)
6,800 shares



4.Planned date of implementation


June 27, 2014